- Home
- ELSE vs LPCN Comparison
ELSE vs LPCN Comparison
Compare ELSE & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELSE
- LPCN
- Stock Information
- Founded
- ELSE 1968
- LPCN 1997
- Country
- ELSE United States
- LPCN United States
- Employees
- ELSE N/A
- LPCN N/A
- Industry
- ELSE Industrial Machinery/Components
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- ELSE Industrials
- LPCN Health Care
- Exchange
- ELSE Nasdaq
- LPCN Nasdaq
- Market Cap
- ELSE 14.7M
- LPCN 16.1M
- IPO Year
- ELSE N/A
- LPCN N/A
- Fundamental
- Price
- ELSE $4.65
- LPCN $3.20
- Analyst Decision
- ELSE
- LPCN Strong Buy
- Analyst Count
- ELSE 0
- LPCN 2
- Target Price
- ELSE N/A
- LPCN $9.00
- AVG Volume (30 Days)
- ELSE 29.0K
- LPCN 29.1K
- Earning Date
- ELSE 08-08-2025
- LPCN 08-07-2025
- Dividend Yield
- ELSE N/A
- LPCN N/A
- EPS Growth
- ELSE 14.32
- LPCN N/A
- EPS
- ELSE 0.11
- LPCN N/A
- Revenue
- ELSE $9,368,000.00
- LPCN $3,674,834.00
- Revenue This Year
- ELSE N/A
- LPCN N/A
- Revenue Next Year
- ELSE N/A
- LPCN N/A
- P/E Ratio
- ELSE $43.17
- LPCN N/A
- Revenue Growth
- ELSE 7.01
- LPCN N/A
- 52 Week Low
- ELSE $3.65
- LPCN $2.68
- 52 Week High
- ELSE $5.50
- LPCN $7.61
- Technical
- Relative Strength Index (RSI)
- ELSE 60.30
- LPCN 48.82
- Support Level
- ELSE $4.51
- LPCN $3.10
- Resistance Level
- ELSE $4.75
- LPCN $3.39
- Average True Range (ATR)
- ELSE 0.20
- LPCN 0.17
- MACD
- ELSE 0.02
- LPCN 0.01
- Stochastic Oscillator
- ELSE 82.43
- LPCN 25.00
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.